![Marc-André Blais](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc-André Blais
Direttore/Membro del Consiglio presso Prognomix, Inc.
Posizioni attive di Marc-André Blais
Società | Posizione | Inizio | Fine |
---|---|---|---|
Prognomix, Inc.
![]() Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - | - |
Segretario Aziendale | - | - |
Storia della carriera di Marc-André Blais
Statistiche
Distribuzione geografica
Canada | 2 |
Posizioni
Director/Board Member | 1 |
Corporate Secretary | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Prognomix, Inc.
![]() Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
- Borsa valori
- Insiders
- Marc-André Blais
- Esperienza